Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Pacific Health Care Organization (PFHO) Shares Outstanding (Weighted Average) (2016 - 2025)

Pacific Health Care Organization (PFHO) has 16 years of Shares Outstanding (Weighted Average) data on record, last reported at $12.8 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $12.8 million; the TTM value through Sep 2025 reached $12.8 million, changed 0.0%, while the annual FY2024 figure was $12.8 million, 0.0% changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $12.8 million in Q3 2025 per PFHO's latest filing, roughly flat from $12.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $12.8 million in Q1 2021 and bottomed at $12.8 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $12.8 million, with a median of $12.8 million recorded in 2021.
  • The widest YoY moves for Shares Outstanding (Weighted Average): up 0.0% in 2021, down 0.0% in 2021.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $12.8 million in 2021, then changed by 0.0% to $12.8 million in 2022, then changed by 0.0% to $12.8 million in 2023, then changed by 0.0% to $12.8 million in 2024, then changed by 0.0% to $12.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $12.8 million in Q3 2025, $12.8 million in Q2 2025, and $12.8 million in Q1 2025.